Stephen P. Mawer Sells 3,655 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Stephen P. Mawer sold 3,655 shares of the stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $12.88, for a total transaction of $47,076.40. Following the sale, the director now directly owns 287,307 shares of the company's stock, valued at $3,700,514.16. The trade was a 1.26 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Calumet Specialty Products Partners Trading Down 2.2 %

Shares of CLMT stock traded down $0.29 during mid-day trading on Friday, reaching $13.16. The stock had a trading volume of 1,425,518 shares, compared to its average volume of 735,015. The business's fifty day moving average is $14.72 and its 200-day moving average is $18.49. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of -4.77 and a beta of 1.88. Calumet Specialty Products Partners, L.P. has a 1-year low of $9.97 and a 1-year high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($1.06) by $0.59. The business had revenue of $949.50 million for the quarter, compared to analyst estimates of $921.76 million. The business's revenue was down 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.59) earnings per share. On average, analysts forecast that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current year.

Remove Ads

Analyst Ratings Changes

CLMT has been the subject of a number of recent analyst reports. HC Wainwright reissued a "buy" rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and lowered their price target for the stock from $15.00 to $12.00 in a report on Monday, March 17th. TD Cowen downgraded shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and cut their price objective for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Finally, Wells Fargo & Company decreased their price objective on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.80.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.